Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/95085
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Svegliati-Baroni, Gianluca | - |
dc.contributor.author | Gaggini, Melania | - |
dc.contributor.author | Carli, Fabrizia | - |
dc.contributor.author | Barbieri, Chiara | - |
dc.contributor.author | Cucco, Monica | - |
dc.contributor.author | Youne, Ramy | - |
dc.contributor.author | Rosso, Chiara | - |
dc.contributor.author | Bugianesi, Elisabetta | - |
dc.contributor.author | Gastaldelli, Amalia | - |
dc.date.accessioned | 2021-06-21T12:19:05Z | - |
dc.date.available | 2021-06-21T12:19:05Z | - |
dc.date.issued | 2020-06 | - |
dc.identifier.issn | 1478-3223 | pt |
dc.identifier.issn | 1478-3231 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/95085 | - |
dc.description.abstract | Patients with chronic liver disease (CLD), both non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C (CHC), are at high risk of diabetes (T2D), but mechanisms are still unknown. Muscle/liver insulin resistance (IR) and pancreatic dysfunction are the major metabolic defects leading to T2D. However, if the risk of T2D in CLD patients is because of reduced insulin response and/or to IR, and the impact of liver histology has not been investigated. | pt |
dc.language.iso | eng | pt |
dc.publisher | Wiley Online Library | pt |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/634413/EU/Elucidating Pathways of Steatohepatitis | pt |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/691042/EU/Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). | pt |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/72261 | pt |
dc.rights | embargoedAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.title | Mechanisms for increased risk of diabetes in chronic liver diseases | pt |
dc.type | article | - |
degois.publication.firstPage | 2489-2499 | pt |
degois.publication.lastPage | 2499 | pt |
degois.publication.issue | 10 | pt |
degois.publication.title | Liver International | pt |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1111/liv.14556 | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1111/liv.14556 | pt |
degois.publication.volume | 40 | pt |
dc.date.embargo | 2021-06-01 | * |
uc.date.periodoEmbargo | 365 | pt |
item.fulltext | Com Texto completo | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.project.grantno | info:eu-repo/grantAgreement/EC/H2020/634413/EU/Elucidating Pathways of Steatohepatitis | - |
crisitem.project.grantno | FOIE GRAS -Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | - |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
paper HCV NAFLD beta cell LiverInt 2020.pdf | 706.78 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
11
checked on Sep 23, 2024
WEB OF SCIENCETM
Citations
12
checked on Sep 2, 2024
Page view(s)
142
checked on Oct 2, 2024
Download(s)
298
checked on Oct 2, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License